111 results on '"Teipel, S. J."'
Search Results
2. Improving linear modeling of cognitive decline in patients with mild cognitive impairment: comparison of two methods
3. Longitudinal changes of fractional anisotropy in Alzheimer’s disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study
4. Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer’s disease brain
5. Value of CSF β-amyloid1–42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment
6. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease: Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET
7. A novel MRI-biomarker candidate for Alzheimerʼ disease composed of regional brain volume and perfusion variables
8. Strukturelle Magnetresonanztomographie in der Diagnose und Erforschung der Demenz vom Alzheimer-Typ
9. CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimerʼs disease
10. Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment
11. EEG coherence reflects regional corpus callosum area in Alzheimer’s disease
12. Intravenous immunoglobulins containing antibodies against β-amyloid for the treatment of Alzheimer’s disease
13. Improving linear modeling of cognitive decline in patients with mild cognitive impairment: comparison of two methods
14. Longitudinal changes of fractional anisotropy in Alzheimer’s disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study
15. Reduction of Basal Forebrain Cholinergic System Parallels Cognitive Impairment in Patients at High Risk of Developing Alzheimer's Disease
16. Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI
17. Morphological substrate of face matching in healthy ageing and mild cognitive impairment: a combined MRI-fMRI study
18. Fiber Connections between the Cerebral Cortex and the Corpus Callosum in Alzheimer's Disease: A Diffusion Tensor Imaging and Voxel-Based Morphometry Study
19. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease
20. Multizentrische Reliabilität MRT-gestützter Volumetrie des Gehirns
21. Phosphorylated tau predicts rate of cognitive decline in MCI subjects: A comparative CSF study
22. Aktuelle Entwicklungen der strukturellen MRT zur Frühdiagnostik der Alzheimer-Demenz
23. Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer’s disease brain
24. Value of CSF β-amyloid1–42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment
25. Improving linear modeling of cognitive decline in patients with mild cognitive impairment: comparison of two methods.
26. CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects
27. Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF
28. Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer's disease
29. Age-Dependent Differences in Human Brain Activity Using a Face- and Location-Matching Task: An fMRI Study.
30. Demenz mit Lewy-Körperchen. Besserung unter Therapie mit einem Acetylcholinesteraseinhibitor.
31. Association between Cognitive Performance and Cortical Glucose Metabolism in Patients with Mild Alzheimer’s Disease.
32. Regional Distribution of White Matter Hyperintensities in Vascular Dementia, Alzheimer's Disease and Healthy Aging.
33. Value of CSF ß-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
34. Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interlenkin-6 receptor complexi in the diagnosis of Alzheimer's disease
35. Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble
36. Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease.
37. Decreased soluble interleukin-6 receptor in cerebrospinal fluid of patients with Alzheimer's disease
38. Progression of corpus callosum and hippocampus atrophy as independent markers of structural disease progression in Alzheimer's disease
39. Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain
40. Increased diagnostic accuracy in Alzheimer's disease by age-transformed hippocampal volumes
41. Cerebrospinal fluid tau phosphorylated at threonine 231 compared to total tau in Alzheimer's disease patients, controls, and subjects at risk
42. [Structural and functional neuronal connectivity in Alzheimer's disease: a combined DTI and fMRI study].
43. [Current status of cognition-based interventions in Alzheimer's disease].
44. [Alzheimer's disease and vascular dementia. Determination of atrophy of the corpus callosum and cerebral cortex].
45. Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric study.
46. [Neurobiological early diagnosis of Alzheimer's disease].
47. Multicenter assessment of reliability of cranial MRI.
48. Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease.
49. Task difficulty in a simultaneous face matching task modulates activity in face fusiform area.
50. Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.